Nigeria has recorded 239 new cases of COVID-19, bringing a total to 4,151.
Announcing this via its Twitter handle on Saturday night, Nigeria Centre for Disease Control said, “97-Lagos 44-Bauchi 29-Kano 19-Katsina 17-Borno 7-FCT 6-Kwara 5-Oyo 3-Kaduna 3-Sokoto 2-Adamawa 2-Kebbi 2-Plateau 2-Ogun 1-Ekiti.”
NCDC tweeted “Till date, 4151 cases have been confirmed, 745 cases have been discharged and 128 deaths have been recorded in 34 states and the Federal Capital Territory.”
While advising Nigerians on the preventive measures for the coronavirus disease, NCDC stressed the importance of physical distancing, frequent handwashing, and the wearing of face mask in the public.
Nigeria’s virus cases have witnessed a high increase in the last five days after the gradual easing of lockdown in Lagos, Ogun and Abuja.
Meanwhile, Lagos State Governor, Mr Babajide Sanwo-Olu has expressed displeasure over non-compliance by residents to safety guidelines and directives in the wake of gradual easing of lockdown, warning that government would not hesitate to review the terms of easing if the level of compliance continues to nose dive.
Sanwo-Olu, gave the warning while giving an update on COVID-19 situation in the state, during a live broadcast, on Saturday.
The governor, who commended some sectors for their encouraging level of compliance, frowned at flagrant disregard to safety directives by commercial bus and motorcycle operators, with a strict warning to redress forthwith or face severe sanctions.
Already, European Centre for Disease Prevention and Control has reported from 31 December 2019 to 09 May 2020, 3,898,658 cases of COVID-19 (in accordance with the applied case definitions and testing strategies in the affected countries), including 274,290 deaths.
Global Cases:
Africa: 57,860 cases; the five countries reporting most cases are South Africa (8,895), Egypt (8,476), Morocco (5,711), Algeria (5,369) and Ghana (4,012).
Asia: 629,193 cases; the five countries reporting most cases are Turkey (135,569), Iran (104,691), China (83,976), India (59,662) and Saudi Arabia (35,432).
America: 1,690,681 cases; the five countries reporting most cases are United States (1,283,929), Brazil (145,328), Canada (66,434), Peru (61,847) and Mexico (31,522).
Europe: 1,511 902 cases; the five countries reporting most cases are Spain (222,857), Italy (217, 185), United Kingdom (211,364), Russia (187,859) and Germany (168,551).
Oceania: 8,326 cases; the five countries reporting most cases are Australia (6,914), New Zealand (1,142), Guam (151), French Polynesia (60) and Fiji (18).
Others: 696 cases have been reported from an international conveyance in Japan.
Global Deaths:
Africa: 2,155 deaths; the five countries reporting most deaths are Egypt (503), Algeria (488), Morocco (186), South Africa (178) and Nigeria (117).
Asia: 21,432 deaths; the five countries reporting most deaths are Iran (6,541), China (4,637), Turkey (3,689), India (1,981) and Indonesia (943).
America: 100 430 deaths; the five countries reporting most deaths are United States (77,180), Brazil (9,897), Canada (4,569), Mexico (3,160) and Peru (1,714).
Europe: 150 141 deaths; the five countries reporting most deaths are United Kingdom (31,241), Italy (30,201), Spain (26,251), France (26,230) and Belgium (8,521).
Oceania: 125 deaths; the 4 countries reporting deaths are Australia (97), New Zealand (21), Guam (5) and Northern Mariana Islands (2).
Others: Seven deaths have been reported from an international conveyance in Japan. The world has joined hands to find a vaccine for the novel coronavirus and scientists and medical researchers across the globe are scrambling for the first breakthrough.
Since the virus spreads easily and is already overwhelming the healthcare system of most countries, a vaccine is the most effective way of putting a pause on the spread of infectious disease.
At present, almost 80 groups globally are working at break-neck speed for the same, even though a vaccine fit for humans normally takes years to develop. Currently, there are 111 potential vaccines for the SARS-CoV-2 which are in different stages of clinical trials.
(Vanguard)
